Sponsor:
Definium Therapeutics US, Inc.
Code:
NCT07303907
Conditions
Autism Spectrum Disorder
ASD
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
DT402 (R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA))
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-26. This information was provided to ClinicalTrials.gov by Definium Therapeutics US, Inc. on 2026-04-06.